Channel Wealth LLC Astrazeneca PLC Transaction History

Channel Wealth LLC

$374 Billion
Q3 2025

A detailed history of Channel Wealth LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Channel Wealth LLC holds 58,508 shares of AZN stock, worth $5.23 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

58,508

Previous 57,391 1.95%

Holding current value

$5.23 Million

Previous $4.01 Billion 11.93%

% of portfolio

1.2%

Previous 1.13%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$68.72 - $82.11 $76,760 - $91,716	1,117 Added 1.95%	58,508 $4.49 Billion
Q2 2025 Jul 09, 2025	BUY	$64.87 - $75.0 $966,433 - $1.12 Million	14,898 Added 35.06%	57,391 $4.01 Billion
Q1 2025 Apr 10, 2025	BUY	$65.37 - $77.96 $151,527 - $180,711	2,318 Added 5.77%	42,493 $3.12 Billion
Q4 2024 Jan 14, 2025	BUY	$63.2 - $79.58 $1.5 Million - $1.89 Million	23,711 Added 144.02%	40,175 $2.63 Billion
Q3 2024 Oct 31, 2024	SELL	$76.67 - $87.62 $205,398 - $234,733	-2,679 Reduced 13.99%	16,464 $1.28 Billion

Q2 2024 Aug 05, 2024	SELL	$66.81 - $80.83 $2.97 Million - $3.59 Million	-44,464 Reduced 69.9%	19,143 $1.49 Billion
Q1 2024 Apr 12, 2024	BUY	$61.03 - $69.57 $1.3 Million - $1.49 Million	21,354 Added 50.54%	63,607 $4.31 Billion
Q4 2023 Jan 08, 2024	BUY	$61.89 - $69.28 $328,697 - $367,946	5,311 Added 14.38%	42,253 $2.85 Billion
Q3 2023 Oct 24, 2023	BUY	$64.85 - $71.7 $1.22 Million - $1.35 Million	18,853 Added 104.22%	36,942 $2.5 Billion
Q2 2023 Jul 26, 2023	BUY	$69.91 - $75.81 $298,935 - $324,163	4,276 Added 30.96%	18,089 $1.29 Billion
Q1 2023 Apr 27, 2023	BUY	$63.15 - $71.6 $872,290 - $989,010	13,813 New	13,813 $959 Million

Others Institutions Holding AZN

# of Institutions

1,497

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Channel Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channel Wealth LLC with notifications on news.

Account

Channel Wealth LLC Astrazeneca PLC Transaction History